BC Week In Review | Feb 10, 2014
Company News

Microbix, Novartis infectious news

Microbix said the European Patent Office Tribunal ruled in favor of Microbix in a patent challenge filed by Novartis in 2011 relating to Microbix's Virusmax technology. The tribunal ruled that all patent claims are novel...
BioCentury | Jan 4, 2010

4Q approvals

4Q approvals Company Approval Amylin Pharmaceuticals Inc. (NASDAQ:AMLN)/ Eli Lilly and Co. (NYSE:LLY) FDA approves Byetta exenatide to include monotherapy in Type II diabetes AstraZeneca plc (LSE:AZN; NYSE:AZN) FDA approves once-daily Seroquel XR quetiapine as...
BC Week In Review | Dec 7, 2009
Clinical News

Agriflu regulatory update

FDA granted accelerated approval of a BLA from Novartis for Agriflu to prevent infection from influenza virus subtypes A and B. The trivalent inactivated influenza virus vaccine will be made available in the U.S. for...
Items per page:
1 - 3 of 3